Original Research
Published on 16 Feb 2026
Retrospective analysis of transarterial chemoembolization or hepatic arterial infusion chemotherapy combined with lenvatinib with or without PD-1 inhibitor as first-line therapy for unresectable hepatocellular carcinoma with high tumor burden: a propensity score-matched study
in Cancer Immunity and Immunotherapy
- 175 views